Alyeska Investment Group
ANTH

Alyeska Investment Group’s Anthera Pharmaceuticals, Inc. ANTH Stock Holding History

Alyeska Investment Group’s Portfolio ANTH Stock Details ANTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-830,674
Closed -$266K – 583
2018
Q1 		$266K Buy
830,674
+484,663
+140% +$724K ﹤0.01% 427
2017
Q4 		$571K Buy
+346,011
New +$595K ﹤0.01% 405

Other funds holding ANTH

WS
Wedbush Securities Los Angeles, California $3.88B AUM 32.38% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
MAM
Meeder Asset Management Dublin, Ohio $1.96B AUM 48.96% 1-Year Est. Return

Alyeska Investment Group's ANTH Position: Q1 2014 in Review

Alyeska Investment Group sold out of Anthera Pharmaceuticals, Inc. (ANTH) in Q1 2014, closing a stake of 9,100 shares — an estimated $223K sold.

Alyeska Investment Group first reported a position in ANTH in Q2 2013 and held it in 3 quarters. The position peaked at $293K in Q3 2013. 35 funds tracked by Wall St. Rank hold ANTH as of Q1 2014.

  • Alyeska Investment Group reported no remaining Anthera Pharmaceuticals, Inc. position as of Q1 2014 after selling out during the quarter.
  • Alyeska Investment Group sold 9,100 Anthera Pharmaceuticals, Inc. shares in Q1 2014, an estimated $223K.
  • Alyeska Investment Group first reported a position in Anthera Pharmaceuticals, Inc. in Q2 2013 and held it in 3 quarters.
  • Alyeska Investment Group's Anthera Pharmaceuticals, Inc. position peaked at $293K in Q3 2013.
  • 35 funds tracked by Wall St. Rank held Anthera Pharmaceuticals, Inc. as of Q1 2014.

Based on Alyeska Investment Group's 13F filing for Q1 2014, filed 15 May 2014.